EUVIMEDEUVIMED entdecken
Crossref

Effect of certepetide (LSTA‐1) on immune system engagement against pancreatic ductal adenocarcinoma (PDAC): An iLSTA sub‐study

Asia-Pacific Journal of Clinical Oncology · 2026-11 · 22 (S6) · 15-15

DOI: 10.1111/ajco.70230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, online erschienen am 19.11.2026.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2026). Effect of certepetide (LSTA‐1) on immune system engagement against pancreatic ductal adenocarcinoma (PDAC): An iLSTA sub‐study. Asia-Pacific Journal of Clinical Oncology, 22(S6), 15-15. https://doi.org/10.1111/ajco.70230

Vancouver

Effect of certepetide (LSTA‐1) on immune system engagement against pancreatic ductal adenocarcinoma (PDAC): An iLSTA sub‐study. Asia-Pacific Journal of Clinical Oncology. 2026;22(S6):15-15. doi:10.1111/ajco.70230

BibTeX
@article{euvimed2026,
  title = {Effect of certepetide (LSTA‐1) on immune system engagement against pancreatic ductal adenocarcinoma (PDAC): An iLSTA sub‐study},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2026},
  volume = {22},
  number = {S6},
  pages = {15--15},
  doi = {10.1111/ajco.70230}
}
Kostenlos starten →